Dermatology News

Dermatology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ishii N et al. - Randomized controlled trials are necessary to better determine the efficacy and adverse effects of IVIG in the treatment of autoimmune bullous skin diseases. In addition, insights into IVIG's mode of action might enable us to develop novel therapeutics to overcome the current shortage of IVIG.

Related Articles

Linear immunoglobulin A bullous dermatosis
Expert Review of Dermatology, 10/14/09    Relevance Score: 66%

Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data
American Journal of Clinical Dermatology, 10/20/09    Relevance Score: 64%

Prevalence and distribution of solitary oral pigmented lesions: a prospective study
Journal of the European Academy of Dermatology and Venereology, 10/27/09    Relevance Score: 63%

Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus
Clinical and Experimental Dermatology, 10/08/09    Relevance Score: 63%

Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09    Relevance Score: 47%

Today in Autoimmune/Bullous Dz...keeping you current

Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris
Journal of the European Academy of Dermatology and Venereology, 12/02/09

Hyper IgE syndrome with umbilical hernia
Indian Journal of Dermatology, 11/25/09

Pemphigus vegetans in a patient with colonic cancer
Indian Journal of Dermatology, Venereology and Leprology , 11/19/09